* To be consumed as directed by physician.
Concentrate for solution for infusion (sterile concentrate). Clear to opalescent, colourless to pale yellow solution.
The recommended dosage for emergency use of Tocilizumab authorized under this EUA given as a single 60-minute intravenous infusion is:
|Recommended Intravenous Dosage for COVID-19|
|Patients at or above 30 kg weight||8 mg/kg|
If clinical signs or symptoms worsen or do not improve after the first dose, one additional infusion of Tocilizumab may be administered at least 8 hours after the initial infusion.
Maximum Dosage in COVID-19 patients is 800 mg per infusion.
Tocilizumab subcutaneous administration is not authorized for the treatment of COVID-19 patients.
Copyright © 2022 All Rights Reserved by Hetero Healthcare Limited.